parkinson-s-disease

Documents about parkinson-s-disease

• Is Trimethylamine N-oxide a Friend, Foe, or Hormetic Agent in Patients with Parkinson’s Disease: A Focused Review of One Microbial Metabolite#272153BYU ScholarsArchive
• Data Sheet 1_Clinicians’ views on a patient decision aid for deep brain stimulation in Parkinson’s disease.pdf#361736Figshare
• Observational Retrospective Cohort of Patient Support Program Data on Practical Experiences of Treatment with Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease: The ORCHESTRA Study#642352Europe PMC
• Multicentre, randomised, single-blind, parallel group trial to compare the effectiveness of a Holter for Parkinson's symptoms against other clinical monitoring methods: Study protocol#325478Dipòsit Digital de la Universitat de Barcelona
• Reblastatin as a neuroprotective agent in temporal lobe epilepsy and excitotoxic conditions of Alzheimer's disease and Parkinson's disease.#223084NCBI PubMed Central
• Microbiota-Gut-Brain Axis in Neurodegenerative Diseases: The Role of Bacterial Amyloids#471980HAL (France)
• Depressive symptoms can negatively influence patient reported disease severity after subthalamic nucleus stimulation for Parkinson's disease.#360827NCBI PubMed Central
• Understanding aperiodic neural activity : methodological considerations, association with pathologies and modulation#156054HAL (France)
• Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients with Levodopa Induced Dyskinesia#841761ClinicalTrials.gov
• Telehealth Allied Health Care With People Who Have Parkinson's Disease Living in Rural Nevada and Wyoming#810868ClinicalTrials.gov
• tACS Modulates Speech and Cognitive Impairments in People With PD by Targeting the Medial Frontal Cortex#875517ClinicalTrials.gov
• Behavioural Addictions Occurring During a Dopaminergic Treatment Prescribe Under Parkinson's Disease: Study of the Psychopathological, Neurological, Pharmacokinetic and Genetic Profiles#873825ClinicalTrials.gov
• [Research progress on intelligent brain age prediction methods in diagnosis of Parkinson's disease].#143185NCBI PubMed Central
• An Immuno-Infrared Sensor Detects Preclinical Alzheimer's and Parkinson's Disease by Protein Misfolding.#174463NCBI PubMed Central
• Proprioceptive Exercise in Parkinson's Disease#846943ClinicalTrials.gov
• Impaired α-Synuclein aggregate clearance in neuronal cells drive their spread to microglia through tunneling nanotubes#356913Dipòsit Digital de la Universitat de Barcelona
• Exploring the relationship between GBA1 host genotype and gut microbiome in the GBA1L444P/WT mouse model: implications for Parkinson’s disease pathogenesis#442586HAL (France)
• Remotely Prescribed and Monitored Home-based Gait-and-balance Augmented Reality Exergaming for People With Parkinson's Disease.#811191ClinicalTrials.gov
• Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease#856922ClinicalTrials.gov
• Comparative Effects of Virtual Reality and Proprioceptive Neuromuscular Facilitation in Patients With Parkinson's Disease#862561ClinicalTrials.gov
• Temporal dynamics of cognitive functioning in people with Parkinson's disease#5525Europe PMC
• Pre-beta burst dynamics in Parkinson’s disease: distinguishing signal from artifact#203153PMC Full-Text (OAI)
• Nonmotor Symptoms in Parkinson's Disease: Neurophysiology Biomarkers and Neuromodulation Approaches.#218859NCBI PubMed Central
• Cell-based regenerative interventions in Parkinson's disease: Overcoming pharmacological limitations.#223036NCBI PubMed Central
• Patient-Reported Communication Decline Following Deep Brain Stimulation in Parkinson's Disease.#317928NCBI PubMed Central
• An N-acylphosphatidylethanolamine-LRRK2 axis controls lysosomal homeostasis in Parkinson s disease#329313bioRxiv / medRxiv
• EYE movement abnormalities in Parkinson's disease: optometric screening and rehabilitation.#330744NCBI PubMed Central
• Modelling Parkinson’s Disease pathology using MITF mutant mice#369423ADA University of Tartu Library
• Creative thinking in Parkinson's disease: A systematic review and meta-analysis.#375170NCBI PubMed Central
• Metabolomic signatures for diagnosis and clinical severity in Parkinson's disease.#380803NCBI PubMed Central
• When rhythm guides speech production: insights from Parkinson’s disease and spinocerebellar ataxia#398710HAL (France)
• Individualized Bayesian Inference Identifies Novel Genetic Variants for Parkinson's Disease.#422956NCBI PubMed Central
• Identifying Blood Proteomic Markers of Parkinson's Disease Dementia Using High-Throughput Approaches#438521bioRxiv / medRxiv
• Comparative evaluation of oxidative stress biomarkers F2-isoprostanes and 8-OHdG in Parkinson's disease and Type 2 Diabetes Mellitus: a systematic review and meta-analysis of human studies#123333Europe PMC
• Safety and Efficacy of botulinumA Toxin (BotoxA) for Treatment of Neurogenic Bladder of Parkinson's Disease#825990ClinicalTrials.gov
• Comparative Effects of Cognitive and Motor Dual Task Training on Balance and Quality Of Life in Parkinson's Patients#858933ClinicalTrials.gov
• Subcutaneous foslevodopa/foscarbidopa (LDp/CDp) in advanced Parkinson’s disease (aPD): societal cost impact analysis for the UK, France, Germany, Spain, and Canada#384363Figshare
• Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's Disease#808010ClinicalTrials.gov
• Italian Translation and Validation of the Non-Motor Fluctuation Assessment (NoMoFA) Questionnaire: an Observational, Multicentric, Cross-sectional, 6-months Duration Study on 200 Consecutive Parkinson's Disease Patients.#827229ClinicalTrials.gov
• Data Sheet 1_Which exercise intervention is most promising for Parkinson's balance? A network meta-analysis.zip#367147Figshare
• Pessoa idosa com doença de Parkinson e a relação da usabilidade na interação com aviamentos de fechos presentes no vestuário#469795Repositório Institucional Unesp
• Monoaminergic Networks of Cognitive and Behavioral Symptoms in Early Parkinson's Disease.#1345NCBI PubMed Central
• Short term heart rate variability is preserved in Parkinson's disease under atomoxetine#13891bioRxiv / medRxiv
• StimVision: smartphone video kinematics to optimize DBS programming in Parkinson's disease#125803Europe PMC
• Predicting long term clinical outcomes in Parkinson's Disease using short term rating scales#138696bioRxiv / medRxiv
• Toward clinical implementation of a metabolic blood biomarker for Parkinson's disease differential diagnosis#158286bioRxiv / medRxiv
• Cognitive effects of STN-DBS on mental rotation performance in Parkinson's disease.#213877NCBI PubMed Central
• Multitarget brain implants enable generalized decoding of Parkinson’s disease symptoms from chronic home recordings#217727Europe PMC
• Force control deficits in rapid eye movement behavior disorder and Parkinson's disease.#224770NCBI PubMed Central
• Fading of brain network fingerprint in Parkinson's disease predicts motor clinical impairment#226776HAL (France)